Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDB vs MRNA✓SelectedUSD · MRNAMDB vs MRNA performance historyLatest closeAs of-5.77%11/17
Stock and ETF performance explorer

MDB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-12.1%
MRNA return
+744.1%
Excess return
-756.1%
Maximum drawdown
-48.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.8%-3.9%-1.8%-5.6%
7D-10.0%-17.6%+7.5%-9.4%
30D-11.5%-5.1%-6.4%-11.3%
3M-31.9%+220.8%-252.7%-34.5%
6M-4.3%+321.7%-326.0%-10.0%
YTD-28.8%+601.3%-630.1%-36.2%
1Y-12.1%+735.2%-747.3%-22.1%
All-12.1%+744.1%-756.1%-22.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling